Literature DB >> 28393498

Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis.

Michael D George1, Jon T Giles2, Patricia P Katz3, Bryant R England4, Ted R Mikuls4, Kaleb Michaud4, Alexis R Ogdie-Beatty5, Said Ibrahim6, Grant W Cannon7, Liron Caplan8, Brian C Sauer9, Joshua F Baker6.   

Abstract

OBJECTIVE: The C-reactive protein (CRP) level and erythrocyte sedimentation rate (ESR) are important disease activity biomarkers in rheumatoid arthritis (RA). This study aimed to determine to what extent obesity biases these biomarkers.
METHODS: Body mass index (BMI) associations with CRP level and ESR were assessed in 2 RA cohorts: the cross-sectional Body Composition (BC) cohort (n = 451), including whole-body dual x-ray absorptiometry measures of fat mass index; and the longitudinal Veterans Affairs Rheumatoid Arthritis (VARA) registry (n = 1,652), using multivariable models stratified by sex. For comparison, associations were evaluated in the general population using the National Health and Nutrition Examination Survey.
RESULTS: Among women with RA and in the general population, greater BMI was associated with greater CRP levels, especially among women with severe obesity (P < 0.001 for BMI ≥35 kg/m2 versus 20-25 kg/m2 ). This association remained after adjustment for joint counts and patient global health scores (P < 0.001 in BC and P < 0.01 in VARA), but was attenuated after adjustment for fat mass index (P = 0.17). Positive associations between BMI and ESR in women were more modest. In men with RA, lower BMI was associated with higher CRP levels and ESR, contrasting with positive associations among men in the general population.
CONCLUSION: Obesity is associated with higher CRP levels and ESR in women with RA. This association is related to fat mass and not RA disease activity. Low BMI is associated with higher CRP levels in men with RA; this unexpected finding remains incompletely explained but likely is not a direct effect of adiposity.
© 2017, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28393498      PMCID: PMC5634905          DOI: 10.1002/acr.23229

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  33 in total

1.  Interpretation of whole body dual energy X-ray absorptiometry measures in children: comparison with peripheral quantitative computed tomography.

Authors:  Mary B Leonard; Justine Shults; Dawn M Elliott; Virginia A Stallings; Babette S Zemel
Journal:  Bone       Date:  2004-06       Impact factor: 4.398

Review 2.  The impact of recent technological advances on the trueness and precision of DXA to assess body composition.

Authors:  Rebecca J Toombs; Gaele Ducher; John A Shepherd; Mary Jane De Souza
Journal:  Obesity (Silver Spring)       Date:  2011-07-14       Impact factor: 5.002

3.  Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study.

Authors:  D Jawaheer; J Olsen; M Lahiff; S Forsberg; J Lähteenmäki; I G da Silveira; F A Rocha; I M Magalhães Laurindo; L M Henrique da Mota; A A Drosos; E Murphy; C Sheehy; E Quirke; M Cutolo; S Rexhepi; J Dadoniene; S M M Verstappen; T Sokka
Journal:  Clin Exp Rheumatol       Date:  2010-08-30       Impact factor: 4.473

Review 4.  Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

Authors:  Yang Liu; Glen S Hazlewood; Gilaad G Kaplan; Bertus Eksteen; Cheryl Barnabe
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-12-31       Impact factor: 4.794

5.  Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.

Authors:  Maria E C Sandberg; Camilla Bengtsson; Henrik Källberg; Annmarie Wesley; Lars Klareskog; Lars Alfredsson; Saedis Saevarsdottir
Journal:  Ann Rheum Dis       Date:  2014-05-12       Impact factor: 19.103

Review 6.  The Obesity Epidemic and Consequences for Rheumatoid Arthritis Care.

Authors:  Michael D George; Joshua F Baker
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

7.  Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis.

Authors:  Antonios Stavropoulos-Kalinoglou; Giorgos S Metsios; Vasileios F Panoulas; Alan M Nevill; Athanasios Z Jamurtas; Yiannis Koutedakis; George D Kitas
Journal:  Clin Rheumatol       Date:  2008-12-19       Impact factor: 2.980

8.  Sex differences in assessment of obesity in rheumatoid arthritis.

Authors:  Patricia P Katz; Jinoos Yazdany; Laura Trupin; Gabriela Schmajuk; Mary Margaretten; Jennifer Barton; Lindsey A Criswell; Edward H Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-01       Impact factor: 4.794

9.  Association of high body mass index with decreased treatment response to combination therapy in recent-onset rheumatoid arthritis patients.

Authors:  L Heimans; M van den Broek; S le Cessie; B Siegerink; N Riyazi; K H Han; P J S M Kerstens; T W J Huizinga; W F Lems; C F Allaart
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-08       Impact factor: 4.794

10.  Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years.

Authors:  Joshua F Baker; Mikkel Ostergaard; Michael George; Justine Shults; Paul Emery; Daniel G Baker; Philip G Conaghan
Journal:  Ann Rheum Dis       Date:  2014-08-04       Impact factor: 19.103

View more
  20 in total

1.  Obesity, Weight Loss, and Progression of Disability in Rheumatoid Arthritis.

Authors:  Joshua F Baker; Bryant R England; Ted R Mikuls; Harlan Sayles; Grant W Cannon; Brian C Sauer; Michael D George; Liron Caplan; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-12       Impact factor: 4.794

2.  Rheumatoid arthritis: Obesity skews markers of inflammation.

Authors:  Sarah Onuora
Journal:  Nat Rev Rheumatol       Date:  2017-04-27       Impact factor: 20.543

3.  Computational deconvolution of synovial tissue cellular composition: presence of adipocytes in synovial tissue decreased during arthritis pathogenesis and progression.

Authors:  Wenhui Wang; Li Wang; Percio S Gulko; Jun Zhu
Journal:  Physiol Genomics       Date:  2019-05-17       Impact factor: 3.107

4.  2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures.

Authors:  Bryant R England; Benedict K Tiong; Martin J Bergman; Jeffrey R Curtis; Salahuddin Kazi; Ted R Mikuls; James R O'Dell; Veena K Ranganath; Alex Limanni; Lisa G Suter; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-11-11       Impact factor: 4.794

Review 5.  Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.

Authors:  Bryant R England; Geoffrey M Thiele; Daniel R Anderson; Ted R Mikuls
Journal:  BMJ       Date:  2018-04-23

6.  Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis.

Authors:  Carson Maynard; Ted R Mikuls; Grant W Cannon; Bryant R England; Philip G Conaghan; Mikkel Østergaard; Daniel G Baker; Gail Kerr; Michael D George; Jennifer L Barton; Joshua F Baker
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-03       Impact factor: 4.794

Review 7.  The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis.

Authors:  Dilli Poudel; Michael D George; Joshua F Baker
Journal:  Curr Rheumatol Rep       Date:  2020-08-01       Impact factor: 4.592

Review 8.  Obesity and Cancer: Existing and New Hypotheses for a Causal Connection.

Authors:  Trevor W Stone; Megan McPherson; L Gail Darlington
Journal:  EBioMedicine       Date:  2018-02-27       Impact factor: 8.143

9.  Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registry.

Authors:  Sytske Anne Bergstra; Cornelia F Allaart; David Vega-Morales; Marieke De Buck; Elizabeth Murphy; Karen Salomon Escoto; Tom W J Huizinga
Journal:  RMD Open       Date:  2020-06

10.  Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis.

Authors:  Martin Schäfer; Yvette Meißner; Jörn Kekow; Sylvia Berger; Sven Remstedt; Bernhard Manger; Joachim Listing; Anja Strangfeld; Angela Zink
Journal:  Rheumatology (Oxford)       Date:  2020-08-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.